Approvals/TGA/ARNUITY ELLIPTA fluticasone furoate 50 microgram powder for inhalation dry powder inhaler

Approved

STANDARD

ARNUITY ELLIPTA fluticasone furoate 50 microgram powder for inhalation dry powder inhaler

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 50eaa28abbd99671
Product Name: ARNUITY ELLIPTA fluticasone furoate 50 microgram powder for inhalation dry powder inhaler
Artg Id: 300141
Artg Name: ARNUITY ELLIPTA fluticasone furoate 50 microgram powder for inhalation dry powder inhaler
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2019-03-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

50eaa28abbd99671

Type

Standard